Drug × Cancer matrix

Each row is a drug, each column a cancer subtype. Cells show the strongest known association for that drug in that cancer: approved clinical trial or blank. The repositionable flag means the drug appears as a synthetic-lethal repositioning candidate in cansar; it’s gene-level, not cancer-level.

Cancer key
GBM — Glioblastoma (CNS astrocytoma grade IV) LUAD — Lung adenocarcinoma SCLC — Small cell lung carcinoma LUSC — Lung squamous cell carcinoma OAC — Oesophageal adenocarcinoma OSCC — Oesophageal squamous cell carcinoma PDAC — Pancreatic ductal adenocarcinoma
Clear
Showing 34 of 34 matching drugs for TSPO — including drugs targeting any of its 24 synthetic-lethal partners , sorted by total cancer coverage.
Drug Target Relationship GBM LUAD SCLC LUSC OAC OSCC PDAC Reposition #cancers
alpidem TSPO Direct yes 0
atorvastatin, temozolomide, radiotherapy HMGCR SSL via HMGCR 1
irinotecan, cisplatin, simvastatin HMGCR SSL via HMGCR 1
lutetium lu 177 dotatate, capecitabine, temozolomide, quality-of-life assessment, questionnaire administration SSTR5 SSL via SSTR5 1
medical cannabis HMGCR SSL via HMGCR 1
nabiximols, temozolomide, nabiximols-matched placebo HMGCR SSL via HMGCR 1
rosuvastatin HMGCR SSL via HMGCR yes 1
ryz101, everolimus, sunitinib, octreotide, lanreotide SSTR5 SSL via SSTR5 1
sorafenib, radiofrequency ablation (rfa) or surgery, everolimus, lanreotide SSTR5 SSL via SSTR5 1
atorvastatin HMGCR SSL via HMGCR yes 0
atorvastatin calcium HMGCR SSL via HMGCR yes 0
cerivastatin HMGCR SSL via HMGCR yes 0
cerivastatin sodium HMGCR SSL via HMGCR yes 0
fluvastatin HMGCR SSL via HMGCR yes 0
fluvastatin sodium HMGCR SSL via HMGCR yes 0
lanreotide SSTR5 SSL via SSTR5 yes 0
lanreotide acetate SSTR5 SSL via SSTR5 yes 0
lemborexant HCRTR1 SSL via HCRTR1 yes 0
lovastatin HMGCR SSL via HMGCR yes 0
midostaurin PRKCZ SSL via PRKCZ yes 0
octreotide SSTR5 SSL via SSTR5 yes 0
octreotide acetate SSTR5 SSL via SSTR5 yes 0
pasireotide SSTR5 SSL via SSTR5 yes 0
pasireotide diaspartate SSTR5 SSL via SSTR5 yes 0
pasireotide pamoate SSTR5 SSL via SSTR5 yes 0
pitavastatin HMGCR SSL via HMGCR yes 0
pitavastatin calcium HMGCR SSL via HMGCR yes 0
pitavastatin magnesium HMGCR SSL via HMGCR yes 0
pitavastatin sodium HMGCR SSL via HMGCR yes 0
pravastatin HMGCR SSL via HMGCR yes 0
pravastatin sodium HMGCR SSL via HMGCR yes 0
rosuvastatin calcium HMGCR SSL via HMGCR yes 0
simvastatin HMGCR SSL via HMGCR yes 0
suvorexant HCRTR1 SSL via HCRTR1 yes 0
Approval data manually curated from National Cancer Institute and Drugs@FDA. Clinical trials from ClinicalTrials.gov. Repositionable list from cansar.ai.